Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Autoimmune Diseases
Vol. 3, Issue 2, 2016
September 17, 2015 EDT
Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study
Tao Gu
,
Neel Shah
,
Gaurav Deshpande
,
Derek H. Tang
,
Debra F. Eisenberg
,
David J. Harrison
,
managed care
cost
effectiveness
biologics
rheumatoid arthritis
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9830
JHEOR
1.
Gu T, Shah N, Deshpande G, Tang DH, Eisenberg DF, Harrison DJ. Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study.
JHEOR
. 2015;3(2):122-131.
doi:10.36469/9830
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats